Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline

 Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline

Biogen and Apple Collaborate to Launch Virtual Study on Cognitive Decline

Shots:

  • Biogen and Apple collaborated to evaluate the role of Apple Watch and iPhone in monitoring cognitive performance and screening for the decline in cognitive health including mild cognitive impairment (MCI)
  • The study will initiate in late 2021 and will enroll participants including young and aging adults with a range of cognitive performance
  • The study focuses to identify digital biomarkers to aid monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as AD

Click here ­to­ read full press release/ article | Ref: Biogen | Image: MyHealthyApp

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post